Home > PS Ratio > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of SENORES PHARMACEUTICALS is 9.06.

Share Price ₹1,275.9Jun 24,2026
Market Cap ₹5,881.9 Cr
Sales-TTM₹649.5 CrTTM-Consolidated Results
Price/Sales9.06xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results
SENORES PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SENORES PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SENORES PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹5,881.9 Cr] as on Jun 24,2026

(/) Sales [ ₹649.5 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 9.06x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SENORES PHARMACEUTICALS , the investors are currently willing to pay '9.06 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SENORES PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of SENORES PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of SENORES PHARMACEUTICALS


PS Ratio Performance Analysis for SENORES PHARMACEUTICALS

- SENORES PHARMACEUTICALS 's latest p/e ratio is 9.06x.

- SENORES PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 1.66x.

- SENORES PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, SENORES PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 6.62x.

- SENORES PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does SENORES PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SENORES PHARMACEUTICALS 649.59.065,881.9
SUN PHARMACEUTICAL INDUSTRIES LTD58,462.07.69449,803.0
DIVIS LABORATORIES LTD10,560.016.97179,219.0
TORRENT PHARMACEUTICALS LTD13,980.010.90152,417.0
CIPLA LTD28,162.64.12116,116.0
DR REDDYS LABORATORIES LTD33,700.23.29110,874.0
MANKIND PHARMA LTD14,277.67.16102,256.0
LUPIN LTD27,958.03.87108,264.0
ZYDUS LIFESCIENCES LTD27,148.44.04109,636.0
AUROBINDO PHARMA LTD33,653.12.6288,015.6
LAURUS LABS LTD6,812.911.5378,549.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SENORES PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.62x
Max industry PS 16.97x
Median industry PS 7.16x
Average industry PS 7.39x



You may also like the below Video Courses